X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-05 | YMAB | Rajah Vignesh | SVP, CHIEF MEDICAL OFFICER | S - Sale | $16.53 | -1,711 | 38,155 | -4% | -$28,283 | ||||||
2024-03-05 | YMAB | Gad Thomas | CHIEF BUSINESS OFFICER | S - Sale | $16.44 | -3,900 | 483,732 | -1% | -$64,116 | ||||||
2024-03-05 | YMAB | Smith Susan Laura | SVP, CHIEF COMMERCIAL OFFICER | S - Sale | $16.55 | -1,682 | 33,918 | -5% | -$27,837 | ||||||
M | 2023-12-13 | YMAB | Gad Thomas | Chief Business Officer | S - Sale | $6.67 | -150,000 | 415,532 | -27% | -$1,001,000 | |||||
2023-12-11 | YMAB | Wg Biotech Aps | Dir | P - Purchase | $6.85 | +6,455 | 4,559,233 | 0% | +$44,232 | ||||||
2023-12-11 | YMAB | Wedell-Wedellsborg Johan | Dir | P - Purchase | $6.85 | +6,455 | 4,559,233 | 0% | +$44,232 | ||||||
M | 2023-12-07 | YMAB | Wg Biotech Aps | Dir | P - Purchase | $6.98 | +127,549 | 4,552,778 | +3% | +$890,411 | |||||
M | 2023-12-07 | YMAB | Wedell-Wedellsborg Johan | Dir | P - Purchase | $6.98 | +127,549 | 4,552,778 | +3% | +$890,411 | |||||
2023-11-29 | YMAB | Wg Biotech Aps | Dir | P - Purchase | $5.97 | +51,837 | 4,425,229 | +1% | +$309,477 | ||||||
2023-11-29 | YMAB | Wedell-Wedellsborg Johan | Dir | P - Purchase | $5.97 | +51,837 | 4,425,229 | +1% | +$309,477 | ||||||
M | 2023-11-27 | YMAB | Wedell-Wedellsborg Johan | Dir | P - Purchase | $5.59 | +93,187 | 4,373,392 | +2% | +$521,294 | |||||
M | 2023-11-27 | YMAB | Wg Biotech Aps | Dir | P - Purchase | $5.59 | +93,187 | 4,373,392 | +2% | +$521,294 | |||||
M | 2023-11-20 | YMAB | Gad Thomas | Chief Business Officer | S - Sale | $5.30 | -150,000 | 565,532 | -21% | -$795,383 | |||||
2023-05-15 | YMAB | Wedell-Wedellsborg Johan | Dir | P - Purchase | $9.65 | +101,740 | 4,280,205 | +2% | +$981,404 | ||||||
2023-05-15 | YMAB | Wg Biotech Aps | See Remarks | P - Purchase | $9.65 | +101,740 | 4,280,205 | +2% | +$981,404 | ||||||
2022-11-15 | YMAB | Rajah Vignesh | SVP, CMO | P - Purchase | $4.92 | +1,195 | 4,266 | +39% | +$5,884 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |